resources

Application of MacroFLUX™ Apparatus for Screening Formulations before Bioequivalent Studies

Application of MacroFLUX™ Apparatus for Screening Formulations before Bioequivalent Studies

Poster

Preview - This content has been restricted to logged in users only.

MacroFLUX bioequivalence study between benchmark brand name drug and its generic formulation predicted by comparing flux measurements
Application of MacroFLUX™ Apparatus for Screening Formulations before Bioequivalent Studies

Poster

Novel device MacroFLUX™ that integrates absorption chamber into USP 2 dissolution bath was used to demonstrate that differences in bioequivalence study between benchmark brand name drug and its generic formulation could have been quantitatively predicted by comparing flux measurements for these formulations.

Previous post